Advertisement Pharmaceutical Business review - Page 4144 of 5287 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 25, 2026

Takeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1

Takeda has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Orzeyful (oveporexton) to treat narcolepsy type 1 in adults.

Continue
The MHLW approval was supported by results from the global Phase III FirstLight and RadiantLight clinical studies. Credit: DW2630 / Shutterstock.com.
August 25, 2026

Lundbeck’s asedebart receives EC orphan designation in Cushing’s syndrome

Cushing’s syndrome of endogenous origin is a rare endocrine disease caused in most instances by excessive ACTH production. Credit: Arif biswas / Shutterstock.com.
August 24, 2026

Gossamer Bio announces $250m in funding to advance seralutinib

Seralutinib is intended for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. Credit: Green Apple/Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Johnson & Johnson’s multiple myeloma treatment secures EC approval
  2. WellSpan and Johns Hopkins renew partnership for advanced cancer care access
  3. Charles River and MVC to develop enterovirus vaccine
  4. FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy
  5. SandboxAQ introduces AQPotency for virtual drug screening

PRESS RELEASES

Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography